Scholarly Index
Jérémie Sellam
Inserm; 11,845 total citations; 435 total publications; best world rank #58
Inserm
11,845Total citations
435Total publications
56H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Osteoarthritis Treatment and Mechanisms | Lifetime | 330 | FR 10 | 98.40 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 411 | FR 24 | 98.27 |
| Inflammatory mediators and NSAID effects | Lifetime | 579 | FR 11 | 96.87 |
| Systemic Lupus Erythematosus Research | Lifetime | 965 | FR 55 | 97.35 |
| Spondyloarthritis Studies and Treatments | Lifetime | 440 | FR 30 | 95.86 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 927 | FR 54 | 94.71 |
| Salivary Gland Disorders and Functions | Lifetime | 777 | FR 27 | 92.93 |
| Vagus Nerve Stimulation Research | Lifetime | 786 | FR 18 | 80.84 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 58 | FR 2 | 98.18 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 242 | FR 11 | 96.26 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 80 | FR 2 | 90.12 |
| Nicotinic Acetylcholine Receptors Study | 2021-2025 | 78 | FR 6 | 89.43 |
| Vagus Nerve Stimulation Research | 2021-2025 | 137 | FR 4 | 84.68 |
| Chemokine receptors and signaling | 2021-2025 | 692 | FR 26 | 55.08 |
| Skin Diseases and Diabetes | 2021-2025 | 888 | FR 65 | 25.46 |